High ALDH1 expression has been shown to correlate with poor prognosis in breast cancer patients [20], and has been associated with early relapse, metastasis development, therapy resistance and poor clinical outcome [7,8,21,22,23]. This evidence concerns the gene ALDH1A1 and breast carcinoma.